HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Ishikawa Selected Research

Interferons

1/2017Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.
8/2001Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection.
7/2001[Interferon therapy to chronic hepatitis type C for the prevention of hepatocarcinogenesis].
4/2000Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Ishikawa Research Topics

Disease

43Neoplasms (Cancer)
12/2021 - 01/2000
18Breast Neoplasms (Breast Cancer)
04/2015 - 09/2000
14Hepatocellular Carcinoma (Hepatoma)
01/2017 - 06/2000
14Stomach Neoplasms (Stomach Cancer)
07/2014 - 03/2000
13Carcinoma (Carcinomatosis)
12/2005 - 08/2000
12Neoplasm Metastasis (Metastasis)
05/2007 - 08/2000
8Infections
01/2017 - 04/2000
8Lymphatic Metastasis
07/2010 - 07/2000
7Colorectal Neoplasms (Colorectal Cancer)
08/2017 - 08/2000
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2017 - 03/2000
7Carcinogenesis
07/2014 - 10/2000
7Inflammation (Inflammations)
07/2010 - 01/2001
6Colonic Neoplasms (Colon Cancer)
02/2007 - 05/2000
5Fibrosis (Cirrhosis)
06/2017 - 04/2000
5Mitral Valve Insufficiency (Mitral Regurgitation)
09/2013 - 08/2000
5Body Weight (Weight, Body)
10/2010 - 02/2000
4Leukemia
01/2017 - 01/2000
4Rupture
09/2013 - 07/2009
4Leukopenia
11/2009 - 08/2000
4Atherosclerosis
11/2009 - 01/2001
4Necrosis
05/2005 - 11/2000
4Unstable Angina
10/2004 - 09/2000
4Myocardial Infarction
08/2001 - 07/2000
3Liver Diseases (Liver Disease)
12/2021 - 06/2000
3Hepatitis
06/2017 - 05/2000
3Chronic Hepatitis C
01/2017 - 04/2000
3Cardiovascular Diseases (Cardiovascular Disease)
07/2014 - 01/2001
3Lymphoma (Lymphomas)
06/2010 - 02/2000
3Type 2 Diabetes Mellitus (MODY)
11/2009 - 01/2001
3Reperfusion Injury
08/2009 - 02/2001
3Hypothermia
07/2004 - 06/2000
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2001 - 04/2001
3Pain (Aches)
09/2001 - 01/2001
2Neuralgia (Stump Neuralgia)
11/2020 - 09/2001
2Bacterial Infections (Bacterial Infection)
06/2018 - 02/2011
2Paralysis (Palsy)
01/2018 - 09/2000
2Chronic Hepatitis B
06/2017 - 02/2001
2Triple Negative Breast Neoplasms
07/2016 - 07/2010
2Oligospermia (Oligozoospermia)
04/2013 - 01/2006
2Azoospermia
04/2013 - 01/2006

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
07/2012 - 03/2000
10Messenger RNA (mRNA)IBA
08/2009 - 06/2000
7C-Reactive ProteinIBA
06/2018 - 07/2000
7DNA (Deoxyribonucleic Acid)IBA
06/2017 - 08/2000
7CytokinesIBA
07/2014 - 06/2000
6AntigensIBA
06/2017 - 03/2000
6EnzymesIBA
10/2001 - 03/2000
5Pharmaceutical PreparationsIBA
09/2011 - 08/2000
5Carcinoembryonic AntigenIBA
08/2009 - 09/2000
4InterferonsIBA
01/2017 - 04/2000
4Cisplatin (Platino)FDA LinkGeneric
07/2014 - 08/2000
4Immunoglobulin G (IgG)IBA
08/2011 - 10/2008
4Glucose (Dextrose)FDA LinkGeneric
11/2009 - 07/2000
4Atrial Natriuretic Factor (ANF)IBA
11/2001 - 01/2000
4Creatine Kinase (Creatine Phosphokinase)IBA
08/2001 - 02/2001
4Fluorouracil (Carac)FDA LinkGeneric
08/2001 - 08/2000
4Codon (Codons)IBA
02/2001 - 05/2000
3Biomarkers (Surrogate Marker)IBA
06/2018 - 04/2013
3Coloring Agents (Dyes)IBA
04/2015 - 12/2005
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2014 - 09/2001
3Anesthetics (Anesthetic Agents)IBA
01/2014 - 08/2000
3Testosterone (Sustanon)FDA Link
02/2011 - 11/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2009 - 08/2001
3Hormones (Hormone)IBA
02/2009 - 07/2004
3MucinsIBA
02/2007 - 10/2000
3CarbohydratesIBA
08/2004 - 04/2001
3Interleukin-10 (Interleukin 10)IBA
02/2004 - 04/2000
3Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2004 - 09/2002
3Reactive Oxygen Species (Oxygen Radicals)IBA
07/2003 - 10/2000
3Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2003 - 08/2001
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2002 - 01/2001
3InterleukinsIBA
09/2002 - 04/2000
3Indicators and Reagents (Reagents)IBA
11/2001 - 01/2000
3Irinotecan (Camptosar)FDA LinkGeneric
11/2001 - 08/2000
3Dichlorodiphenyldichloroethane (DDD)IBA
11/2001 - 08/2000
3Benzo(a)pyreneIBA
06/2001 - 01/2000
3Matrix Metalloproteinases (MMPs)IBA
06/2001 - 11/2000
3gamma-glutamylcysteineIBA
03/2001 - 09/2000
3Ligases (Synthetase)IBA
03/2001 - 09/2000
3Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2001 - 11/2000
3Tumor Biomarkers (Tumor Markers)IBA
10/2000 - 09/2000
2Biological ProductsIBA
12/2021 - 03/2013
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2021 - 01/2017
2AlbuminsIBA
12/2021 - 11/2009
2BilirubinIBA
12/2021 - 06/2018
2LigandsIBA
11/2020 - 07/2005
2CholesterolIBA
06/2018 - 02/2000
2oxidized low density lipoproteinIBA
06/2018 - 01/2001
2Dasatinib (BMS 354825)FDA Link
01/2017 - 01/2017
2Furosemide (Lasix)FDA LinkGeneric
09/2013 - 03/2011
2Progesterone Receptors (Progesterone Receptor)IBA
03/2013 - 07/2010
2LipidsIBA
10/2011 - 01/2001
2Nucleic AcidsIBA
10/2011 - 03/2000

Therapy/Procedure

28Therapeutics
01/2017 - 01/2000
9Drug Therapy (Chemotherapy)
07/2014 - 01/2000
6Transplantation
01/2018 - 06/2000
4Hematopoietic Stem Cell Transplantation
06/2013 - 11/2001
4Catheters
03/2010 - 06/2000
3Gastrectomy
12/2005 - 05/2000
3Aftercare (After-Treatment)
10/2001 - 11/2000